- OGT - Precision genomic solutions
Accelerate your clinical trial assay and CDx development programmes in haematological malignancies by partnering with OGT’s precision medicine team Discover more
- Find out about OGT
At OGT we know that behind every sample is a life that can be improved through the right care decisions It is our goal to enable researchers and clinical decision makers worldwide to reach the right decisions for each patient, every time Helping patients to live longer, healthier lives
- OGT company news
Find out about the latest news from OGT, including product launches and updates, new research projects, and other major company updates
- CytoCell MLL (KMT2A) Breakapart FISH Probe - OGT
Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter
- CytoCell fluorescence in situ hybridisation (FISH) - OGT
Developed by scientists, for scientists, OGT's CytoCell ® portfolio offers a comprehensive range of over 545 FISH probes for haematology, solid tumour, cytogenetics and rare disease, supported by our unmatched FISH probe customisation service, myProbes ®
- SureSeq Myeloid MRD NGS Panel - OGT
OGT specializes in the development of superior hybrid capture technology that excels in the detection of complex structural variants and eliminates inaccurate calls caused by alternative PCR-based approaches
- CytoCell myProbes custom FISH probes - OGT
Number of tests required Probe strategy Additional information Keep up-to-date with the latest news from OGT
- CytoCell EVI1 (MECOM) Breakapart FISH Probe - OGT
Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter
|